Form 4 Filing Summary for Wai Conrad

Wai Conrad, CEO of Counterpart Health, reported a sale of 220,426 shares of Class A Common Stock on May 28, 2026, pursuant to a Rule 10b5-1 trading plan. The shares were sold at an average price of $3.99, with individual transactions ranging from $3.92 to $4.04. Following this transaction, Conrad directly owns 1,169,914 shares. An additional 1,390,056 shares are held indirectly in trust for the benefit of Conrad's family, with Conrad acting as a co-trustee.